Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 19/20 | 0.56 |
| ▸ | PTGDR | Q13258 | 2/20 | 0.56 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.53 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.50 |
| ▸ | PHGDH | O43175 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1956758 | 1.00 | PTGER4 (0.56) | PTGER4PTGDRPTGER2PTGER3PHGDH | |
| SCHEMBL1956768 | 0.90 | PTGER4 (0.54) | PTGER4PTGDRPTGER2PTGER3 | |
| SCHEMBL28484982 | 0.90 | PTGER4 (0.54) | PTGER4PTGDRPTGER2PTGER3 | |
| SCHEMBL23089016 | 0.85 | PTGER4 (0.49) | PTGER4PTGDRPTGER2PTGER3 | |
| SCHEMBL23089018 | 0.85 | PTGER4 (0.49) | PTGER4PTGDRPTGER2PTGER3 | |
| SCHEMBL28474778 | 0.79 | PTGER4 (0.42) | PTGER4PTGDRPTGER2PTGER3 | |
| SCHEMBL196469 | 0.78 | PTGER4 (0.43) | PTGER4PTGDRPTGER2PTGER3 | |
| SCHEMBL23089017 | 0.77 | PDE2A (0.41) | PTGER4PTGDRPTGER2PTGER3 | |
| SCHEMBL196468 | 0.75 | SRD5A2 (0.44) | PTGER4PTGDRPTGER2PHGDH | |
| SCHEMBL28933081 | 0.74 | PTGER4 (0.69) | PTGER4PTGER3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111936502-A | Heterobicyclic carboxylic acids and salts thereof | 深圳市原力生命科学有限公司 | 2020-11-13 | — | — | CN | claimed |
| CN-111727044-A | Heterobicyclic carboxylic acids for the treatment of cancer or inflammatory diseases | 深圳市原力生命科学有限公司 | 2020-09-29 | — | — | CN | claimed |
| CN-111936502-B | Heterobicyclic carboxylic acids and salts thereof | 深圳市原力生命科学有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-117643587-A | Heterobicyclic carboxylic acids for the treatment of cancer | 深圳市原力生命科学有限公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-111936502-A | Heterobicyclic carboxylic acids and salts thereof | 深圳市原力生命科学有限公司 | 2020-11-13 | — | — | CN | disclosed |